Latest News and Press Releases

Phase 2 clinical trial underway with first patient dosed in October to support a clear path to Phase 3 based on previous alignment with FDA Patients randomized to either 10 or 20 mg/kg of muzastotug,...

Dr. Matt Sones of Ocean Pediatric Dental Associates in New Jersey shares practical measures parents can take to prevent cavities in their children.

ICP-B794 has demonstrated superior anti-tumor activity in animal models, and exhibited significant tumor-killing effects even in large tumors.

NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Bright Minds Biosciences, Inc. (“Bright Minds,” “BMB” or the “Company”) (NASDAQ: DRUG), a pioneering company focused on developing highly selective 5-HT2...

SOUTH SAN FRANCISCO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway...

SAN FRANCISCO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or...

CAMBRIDGE, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic...

South San Francisco, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- The California Institute for Regenerative Medicine (CIRM) has approved awarding $27 million through three grants across the state to...

Boston, Oct. 30, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Biological and Medical Imaging Reagents: Global Markets” is projected to grow from $26.6 billion in 2025...

Unlike other screening programs, lung cancer screening remains less familiar to many Canadians, but it’s a crucial way to protect your health.